This inventor holds 1 USPTO granted patent. Top assignees: Children's Medical Center Corporation, Harvard College, The Brigham and Women's Hospital, Inc.. Active years: 2017.
Company Filing History:



Years Active: 2017
Title: Caeul Lim: Innovator in Sickle Cell Disease Diagnosis
Introduction
Caeul Lim is an accomplished inventor based in Boston, MA (US). He has made significant contributions to the field of medical diagnostics, particularly in the diagnosis of sickle cell disease. His innovative approach has the potential to improve patient outcomes and enhance diagnostic accuracy.
Latest Patents
Caeul Lim holds a patent for a groundbreaking invention titled "Multiphase systems for diagnosis of sickle cell disease." This patent describes an aqueous multi-phase system that includes two or more phase-separated phases. The first aqueous phase contains a first phase component with a density between about 1.025 g/cm and about 1.095 g/cm, while the second aqueous phase includes a second phase component with a density between about 1.100 g/cm and about 1.140 g/cm. The first density is lower than the second density, and each phase component includes at least one polymer. This innovative system aims to facilitate the diagnosis of sickle cell disease more effectively.
Career Highlights
Throughout his career, Caeul Lim has worked with notable institutions, including Children's Medical Center Corporation and Brigham and Women's Hospital, Inc. His work in these organizations has allowed him to collaborate with leading experts in the medical field and contribute to advancements in healthcare.
Collaborations
Caeul Lim has had the opportunity to work alongside esteemed colleagues such as Ashok A Kumar and George M Whitesides. These collaborations have enriched his research and have played a crucial role in the development of his innovative diagnostic systems.
Conclusion
Caeul Lim's contributions to the field of medical diagnostics, particularly in the diagnosis of sickle cell disease, highlight his innovative spirit and dedication to improving healthcare. His patent and collaborations reflect his commitment to advancing medical technology and enhancing patient care.